Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer

This study is ongoing, but not recruiting participants.

Study NCT00515866 Information provided by AstraZeneca

First Received: August 13, 2007 Last Updated: July 15, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	August 2012
Estimated Primary Completion Date:	August 2011 (Final data collection date for primary outcome measure)